Search

everythinglearnresearchcommunity

for

Search:↓

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Pal-KCV peptide strengthens hair and reduces breakage by up to 52%.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

New compounds may help treat heart disease by activating specific potassium channels.

Customized dermatological treatments effectively address gaps in standard products, especially for complex cases.

Longer treatment with vismodegib lowers relapse risk in basal cell carcinoma.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Kerion, a scalp fungal infection, requires lab confirmation and is treated with antifungal medication and medicated shampoo.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

DermaCult™ Keratinocyte Expansion Medium allows human skin cells to grow longer while keeping their ability to develop properly.

Hinokitiol may help treat hair loss by reducing inflammation and promoting hair growth.

KY19382 speeds up wound healing by activating a specific cell signaling pathway.

Personalized medicine and new technologies offer promising strategies for better skin disease treatments.

The quality of Neelibhringadi Keratailam varies among products, suggesting a need for better standardization and quality control.

Repurposing existing drugs can quickly and cheaply find new treatments for diseases.

EPC-K is stable except at very acidic pH or when exposed to sunlight, and it can decompose in low ethanol concentrations.

Kenikir leaf extract nanosuspension may help inhibit breast cancer cell growth.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Some cosmetics and dermatological drugs can cause allergic reactions and side effects, like skin irritation and systemic issues.

Companies agreed to stop false advertising about their products' health benefits.

Fernblock® helps protect skin cells from pollution and stress, reducing inflammation and damage.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Burdock has potential for new pharmaceutical products due to its medicinal properties.

Ginsenoside compound K shows promise for treating metabolic diseases like diabetes and obesity.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.